AbCellera shares soar in record-breaking IPO


The Vancouver-based biotech firm’s shares debuted at US$20 in its initial public offering on the Nasdaq. They opened at US$61 and rose to an intraday high of US$71.91. (The Logic)

Read this article for free

By entering your e-mail you consent to receiving commercial electronic messages from The Logic Inc. containing news, updates, offers or promotions about The Logic Inc.’s products and services. You can withdraw your consent at anytime. Please refer to our privacy policy or contact us for more details.

Already a subscriber?